ORKA
Oruka Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$74.48
+3.55%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.24x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 1.88x
Liquidity & coverage
- Current ratio
- 38.51x
- Quick ratio
- 38.51x
- Cash ratio
- 38.03x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $861.6M
Cash & dividend
- FCF / debt
- -39.73x
- Cash flow / debt
- -39.64x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026